PDCD1 and toxic epidermal necrolysis: Furthermore, PD-1 inhibitors have been observed to elicit cutaneous reactions characterized by gene expression profiles that resemble those of SJS and TEN, yet they differ from the profiles associated with acute skin graft-versus-host disease or maculopapular rash.